An Evaluation of Brief Behavioral Activation Treatment for Depression With Moderate to Severely Depressed Inpatients - A Small Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Lovisenberg Diakonale Hospital
- Enrollment
- 23
- Primary Endpoint
- Change of Beck's Depression Inventory-II from baseline
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.
Investigators
Martin Myhre
Learning Disability Nurse/MSc Behavior Analysis
Lovisenberg Diakonale Hospital
Eligibility Criteria
Inclusion Criteria
- •Moderate to severe depression (BDI-II \> 28 Points).
- •Admission length of at least 3 days
- •Evaluated to benefit from depression treatment by unit psychiatrist.
Exclusion Criteria
- •Current psychotic disorder
- •Previously diagnosis with psychotic disorder (including Bipolar disorder)
Outcomes
Primary Outcomes
Change of Beck's Depression Inventory-II from baseline
Time Frame: Change from baseline (second day of admission) to discharge from the ward (maximum 21 days, expected average of 10 days).
Secondary Outcomes
- Treatment Evaluation Inventory - Short Form(Prior to discharge from the ward (maximum 21 days, expected average of 10 days)..)
- Credibility and Expectancies Questionnaire(Second day of admission. After first sessions of BATD.)